Valuation BLS Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 10:10:24 02/10/2026 +04			5-day change	1st Jan Change
1.020 ^AUD	0.00%		-0.97%	+142.86%

09-21	BLS Pharmaceuticals Limited(ASX:BLS) added to S&P/ASX All Ordinaries Index	CI
09-14	BLS Pharmaceuticals Limited Announces Appointment of Angus Walker as Alternate Director to Edward Myer, Effective September 14, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Market Cap ¹	17.92	7.682	38.03	10.23	88.76	213.1
Change	-	-57.14%	395.11%	-73.09%	767.35%	140.05%
Enterprise Value (EV) ¹	16.32	5.514	34.75	9.916	82.62	208.2
Change	-	-66.22%	530.16%	-71.46%	733.27%	152%
P/E	-35x	-30x	-13.9x	-0.72x	17.8x	13.9x
PBR	9.53x	4.07x	2.51x	2.84x	7.15x	6.88x
PEG	-	0.6x	-0x	-0x	-0x	0x
Capitalization / Revenue	8.13x	3.09x	7.17x	1.06x	3.03x	2.88x
EV / Revenue	7.4x	2.22x	6.55x	1.03x	2.82x	2.82x
EV / EBITDA	-124x	-38.9x	-20.1x	-9.16x	15.3x	10.3x
EV / EBIT	-109x	-36.2x	-18.9x	-8.75x	16.2x	10.7x
EV / FCF	34.5x	12.4x	-63.8x	-3.81x	29.2x	-112x
FCF Yield	2.9%	8.05%	-1.57%	-26.3%	3.42%	-0.89%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.007999	-0.003999	-0.0144	-0.069	0.023	0.067
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.204	2.485	5.305	9.643	29.28	73.91
EBITDA ¹	-0.132	-0.1416	-1.726	-1.082	5.402	20.13
EBIT ¹	-0.1497	-0.1525	-1.836	-1.133	5.099	19.55
Net income ¹	-0.4957	-0.2365	-1.94	-13.33	4.901	15.4
Net Debt ¹	-1.602	-2.168	-3.287	-0.3176	-6.134	-4.856
Reference price ²	0.280	0.120	0.200	0.050	0.410	0.930
Nbr of stocks (in thousands)	64,015	64,015	190,165	204,665	216,483	229,104
Announcement Date	30/09/21	30/09/22	29/09/23	30/09/24	30/09/25	31/08/26

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BLS PHARMACEUTICALS LIMITED	-	-	-	-	163M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	20.98x	31.37x	12.47x	0.31%	39.07B
Weighted average by Cap.	22.27x	32.04x	13.55x	0.42%